AN2 Therapeutics Inc. (ANTX)
NASDAQ: ANTX
· Real-Time Price · USD
1.31
0.03 (2.34%)
At close: Oct 03, 2025, 3:56 PM
1.30
-0.76%
After-hours: Oct 03, 2025, 04:10 PM EDT
13F Institute Ownership
Total Institutes of 34 in AN2 Therapeutics reduced their positions with a decrease of 2 investors compared to the previous quarter. A reduction of 4.93M shares, as total invested capital declined by $9.14M with ownership percentage dropping from 43.35% to 26.83%.
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio | Filing Date |
|---|---|---|---|---|---|---|
| Almitas Capital LLC | 4.73% | 1.43M | +8.77% | 1.51M | 0.38% | Aug 14, 2025 |
| Vanguard Group Inc | 3.43% | 1.04M | +0.00% | 1.1M | < 0.01% | Aug 11, 2025 |
| Pfizer Inc | 2.37% | 715.29K | +0.00% | 758.21K | 0.13% | Aug 11, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.